0 followers
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.
Eddie J. Sullivan
Ocular Therapeutix
2 followers
Crinetics Pharmaceuticals
1 follower
Phil
2 followers
Bristol-Myers Squibb
207 followers
Formation Bio
2 followers
Viatris
38 followers
Syneos Health
23 followers
Alnylam Pharmaceuticals
23 followers
Catalent
20 followers
Organon
17 followers
NYU Langone Health
16 followers
Explore companies